香港股市 已收市

思派健康 (0314.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
6.150-0.050 (-0.81%)
收市:04:08PM HKT

思派健康

Units 11-13, Tower A
26th Floor Guanzhou Biosciences Innovation Center No. 51, Luoxuan Avenue, Guangzhou International Bi
Guangzhou
China

https://www.medbankshealthtech.com

版塊Healthcare
行業Medical Distribution
全職員工3,082

高階主管

名稱頭銜支付行使價出生年份
Mr. Xuguang MaCEO & Executive Chairman2.03M1971
Mr. Ji LiPresident & Executive Director1.71M1978
Mr. Qi'ang LiChief Operating Officer1982
Ms. Na RenGeneral Counsel & Joint Company Secretary1978
Mr. Teng ZhouChief Strategy Officer1987
Ms. Ching Yi LiJoint Company Secretary
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People's Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. The Physician Research Assistance Business segment offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and others; and services for image management in clinical trials. The Health Insurance Services Business segment provides insurance brokerage services to insurance companies. The company was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.

公司管治

截至 無 止,思派健康 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。